In this article
Estradiol is one of the most studied menopause medicines, and its side effects are well documented. Most are mild and familiar, like breast tenderness or a headache. A few are rare but serious, and those are the ones worth knowing by name. This guide pulls the side effect lists from FDA drug labels, explains how they change depending on whether you take a pill, wear a patch, rub on a gel or cream, or use vaginal estrogen, and walks through the boxed warning in plain English, including what changed recently.
Common estradiol side effects
The Menopause Society's 2022 position statement lists the more common side effects of hormone therapy as nausea, bloating, weight gain, fluid retention, mood swings (mostly linked to the progestogen), breakthrough bleeding, headaches, and breast tenderness [1]. FDA labels for individual products describe a similar picture:
- Headache is among the most common side effects in trials of estradiol gel and the estradiol patch [5, 6].
- Breast pain or tenderness appears on the labels for tablets, gel, patch, and vaginal cream [4, 5, 6, 7].
- Irregular vaginal bleeding or spotting is listed for tablets and vaginal cream [4, 7].
- Stomach symptoms such as nausea, cramps, bloating, or gas [3, 4, 5].
- Fluid retention (edema) was among the most common reactions in patch trials [6].
- Hair loss is listed on the tablet label and by MedlinePlus [3, 4].
- Mood changes, tiredness, and trouble sleeping are listed by MedlinePlus for skin estradiol [3].
MedlinePlus also lists leg cramps, dizziness, weight gain or loss, changes in sex drive, and vaginal discharge or irritation as possible side effects of oral estradiol. It says to tell your doctor if any side effect is severe or does not go away [2].
Is it the estrogen or the progestogen?
If you have a uterus, you are likely taking a progestogen alongside estradiol, and some side effects come from that half of the regimen. The Menopause Society links mood swings mainly to the progestogen [1]. It also notes that oral micronized progesterone is mildly sedating and should be taken at night [1]. Bleeding is another shared effect. In women taking estrogen plus a progestogen, the Menopause Society says unscheduled bleeding that happens more than six months after starting should be investigated [1]. So when something feels off, it helps to tell your clinician exactly what you notice and when, rather than guessing which medicine is responsible. Our guide to progesterone side effects covers that side in more detail.
How side effects differ by route
Estradiol is the same hormone whether you swallow it, wear it, or apply it. What changes is how it gets into your body, and that shapes some of the side effects. Here is how the main forms compare.
| Route | Most common side effects on the label | Route-specific notes |
|---|---|---|
| Oral tablet | Headache, breast pain, irregular bleeding or spotting, stomach cramps or bloating, nausea and vomiting, hair loss [4] | Passes through the liver first; linked to higher blood clot risk than skin estrogen in observational studies [1, 11] |
| Patch | Breast pain, upper respiratory infections, headache, abdominal pain, pain, edema [6] | Application site reactions reported; rotate sites [6] |
| Gel, spray, or cream on the skin | Headache, gas, breast pain (gel) [5] | Skin irritation possible; can transfer to others by touch [3, 5] |
| Low-dose vaginal cream | Headache, breast pain, irregular bleeding or spotting, cramps, nausea, yeast infection or irritation [7] | Minimal absorption into the bloodstream [1] |
Pills
Oral estradiol is processed by the liver before it reaches the rest of your body. The Menopause Society says observational studies suggest less blood clot risk with transdermal (through-the-skin) estrogen than with oral estrogen, though randomized trials comparing the two are lacking [1]. A 2018 meta-analysis found that among women taking estrogen alone, oral but not transdermal estrogen was linked to higher clot risk [11]. Transdermal estrogen has also been linked with less gallbladder disease than oral estrogen in observational studies [1].
Patches
The Climara patch label lists breast pain, upper respiratory tract infections, headache, abdominal pain, pain, and edema as the most common reactions in its trials, and application site reactions in its post-marketing reports [6]. The label says to rotate where you place the patch, waiting at least a week before using the same spot again [6]. Read more in our estradiol patch guide.
Gels, sprays, and creams
In trials of EstroGel, the most common side effects were headache, gas, and breast pain, and skin reactions at the application site were uncommon [5]. MedlinePlus lists skin irritation where the medicine is applied, and warns that topical estradiol can harm other people or pets who touch it, especially men and children [3]. It advises keeping others from touching the area for at least one hour [3]. Our estradiol cream guide covers application in more detail.
Vaginal estrogen
Low-dose vaginal estrogen is used for dryness, irritation, and painful sex. The Menopause Society says it has minimal systemic absorption, does not appear to raise endometrial cancer risk (though trials with biopsy results last only one year), and generally does not need a progestogen added [1]. The Estrace vaginal cream label lists headache, breast pain, irregular bleeding or spotting, stomach cramps, nausea, and vaginal yeast infection or irritation from the applicator among its less serious side effects [7]. See vaginal estrogen cream for more.
The boxed warning, in plain English
A boxed warning is the FDA's most prominent safety warning on a drug label [9]. For years, estrogen labels carried one covering endometrial cancer, cardiovascular disorders, probable dementia, and breast cancer [4, 5, 6]. Much of it came from the Women's Health Initiative (WHI), a large trial that reported higher rates of heart attack, stroke, invasive breast cancer, and blood clots in the lungs, and a higher risk of probable dementia in women 65 and older [4].
Context matters, and this is where the Menopause Society's 2022 statement helps. It says that for women younger than 60, or within 10 years of menopause, with no reason they should not take it, the benefit-risk ratio is favorable for treating hot flashes and preventing bone loss [1]. For women who start more than 10 years after menopause or after 60, the balance looks less favorable because the absolute risks of heart disease, stroke, blood clots, and dementia are higher [1]. For women under 60, it classes the serious risks as rare, a category defined as fewer than 10 cases per 10,000 women per year [1].
What changed in 2025 and 2026
On November 10, 2025, the FDA announced it was starting to remove references to cardiovascular disease, breast cancer, and probable dementia from the boxed warnings on menopause hormone products. It said it was not seeking to remove the endometrial cancer warning for systemic estrogen-alone products [8]. On February 12, 2026, the FDA approved the first labeling changes for six products and said it had asked 29 companies to submit similar changes [9].
The Menopause Society agreed with removing the boxed warning from low-dose vaginal estrogen. It added that systemic estrogen still carries potential risks for some people, that those risks are greater when therapy starts in older women or further from menopause, and that they should be reviewed in detail with anyone starting treatment [10].
Labels are being updated product by product, so the warning on your prescription may still show the older wording. A shorter box does not mean the risks are gone. They are still part of the conversation with your clinician [10].
Serious but less common side effects
The patient information for estradiol tablets lists less common but serious side effects including breast cancer, cancer of the uterus, stroke, heart attack, blood clots, dementia, gallbladder disease, and ovarian cancer [4]. The FDA also notes that for some women hormone therapy may increase the chance of blood clots, heart attacks, strokes, breast cancer, and gallbladder disease [12].
If you have a uterus, estrogen alone raises the risk of endometrial cancer, and the risk grows the longer you take it [2]. Adding a progestogen lowers that risk, which is why the Menopause Society says women with a uterus using systemic estrogen should receive adequate progestogen [1, 12]. Your clinician decides what that looks like for you.
When to call your clinician
FDA labels and MedlinePlus list warning signs that need a call to your healthcare provider right away, or emergency care if they are severe. They include [2, 4, 7]:
- A new breast lump
- Unusual vaginal bleeding
- Changes in vision or speech
- A sudden, new, severe headache
- Severe pain in your chest or legs, with or without shortness of breath
- Sudden swelling or pain in an arm or leg
- Dizziness or faintness, or vomiting
- Yellowing of the skin or eyes
- Swelling of the lips, tongue, or face, or hives
Postmenopausal bleeding should always be checked by a clinician, whatever you are taking [1].
Managing common side effects
Many side effects can be addressed by adjusting the plan, and that is a decision you make with your clinician, not on your own. Here is what the sources recommend:
- Use the lowest dose that helps. The FDA advises using hormone therapy at the lowest dose that helps, for the shortest time you need it [12]. The Menopause Society says treatment should be individualized and reevaluated periodically [1].
- Talk about the route. Formulation, dose, and route all affect risk, according to the Menopause Society [1]. If pill side effects bother you, ask whether another form fits better.
- Follow application directions. Rotate patch sites [6]. Let gels and sprays dry, and ask before using lotion or sunscreen on the area, since they can change absorption [3, 5].
- Keep up with checkups. The labels advise talking regularly with your healthcare provider about whether to continue, yearly breast and pelvic exams, and mammograms as your provider recommends [4, 7].
- Manage heart risk factors. The Estrace vaginal cream label advises managing high blood pressure, high cholesterol, diabetes, excess weight, and tobacco use [7]. MedlinePlus notes smoking may increase side effects of topical estradiol [3].
Do not stop, start, or change your estradiol dose without talking to your clinician first. For a broader look at the benefits and risks, read is HRT safe?, and if weight is your concern, see does HRT cause weight gain?
Estradiol through WarriorBabe Health
WarriorBabe Health offers estradiol as an oral tablet, a topical cream, a weekly patch, and a low-dose vaginal cream, each by prescription after a licensed clinician reviews your health history. Our products are compounded by a licensed pharmacy. The FDA does not verify the safety, effectiveness, or quality of compounded drugs. FDA-approved estradiol products exist, and the FDA recommends FDA-approved hormone therapies [12]. The Menopause Society notes that compounded hormones lack a label outlining risks and may be overdosed or underdosed [1]. Your clinician can talk through these trade-offs with you.
You can compare options on the hormones page or take the 2-minute quiz. Your clinician decides whether estradiol is right for you, which form, and at what dose.
Frequently asked questions
What are the most common side effects of estradiol?
FDA labels most often list headache, breast pain or tenderness, irregular bleeding or spotting, nausea, and stomach cramps or bloating [4, 5, 7]. The Menopause Society also names weight gain, fluid retention, and mood swings, which are often linked to the progestogen [1]. Many are mild. Tell your clinician about any that are severe or do not go away [2].
Does estradiol cause weight gain?
Weight gain is listed as a possible side effect, and the Menopause Society includes weight gain and fluid retention among the more common effects of hormone therapy [1, 2]. The same statement also says hormone therapy may help reduce the build-up of belly fat around the menopause transition [1]. If you notice changes, talk with your clinician rather than adjusting your dose yourself.
Is the patch or cream gentler than estradiol pills?
Estrogen through the skin skips the liver's first pass. Observational studies link it with lower blood clot and gallbladder risk than pills, though randomized trials comparing routes are lacking [1, 11]. Skin forms bring their own issues, like irritation where applied and the chance of transferring the medicine to others by touch [3, 6]. Your clinician can help weigh which fits you.
Does vaginal estrogen have the same side effects as pills?
Not quite. Low-dose vaginal estrogen has minimal absorption into the bloodstream, and the Menopause Society says it generally does not need a progestogen [1]. Its label lists headache, breast pain, irregular bleeding, cramps, nausea, and vaginal irritation or yeast infection [7]. The Menopause Society supported removing the boxed warning from low-dose vaginal estrogen [10].
Did the FDA remove the boxed warning on estrogen?
Partly. In November 2025 the FDA began removing heart disease, breast cancer, and probable dementia language from the boxed warning on menopause hormone products, while keeping the endometrial cancer warning for systemic estrogen-alone products [8]. It approved the first six updated labels in February 2026 [9]. Other labels may still show the older wording while updates continue.
References
- The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
- MedlinePlus. Estradiol. U.S. National Library of Medicine. medlineplus.gov/druginfo/meds/a682922.html
- MedlinePlus. Estradiol Topical. U.S. National Library of Medicine. medlineplus.gov/druginfo/meds/a605041.html
- Estradiol tablets, USP. Prescribing information and patient information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=170ec388-d399-4543-8743-208394b38904&audience=professional
- EstroGel 0.06% (estradiol gel) for topical use. Prescribing information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=762ac371-bb8b-47e7-b48f-e80d452c9dd4
- Climara (estradiol transdermal system). Prescribing information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e9702c4-f2d7-4ea8-b6e8-7dca31671864
- Estrace (estradiol vaginal cream, USP 0.01%). Prescribing information and patient information. DailyMed, U.S. National Library of Medicine. dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=da52a602-f2a2-4382-be07-30351c58cc4b&type=display
- U.S. Food and Drug Administration. HHS Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. November 10, 2025. www.fda.gov/news-events/press-announcements/hhs-advances-womens-health-removes-misleading-fda-warnings-hormone-replacement-therapy
- U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products. February 12, 2026. www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
- The Menopause Society. The Menopause Society Comments on the FDA Announcement on Hormone Therapy. November 10, 2025. menopause.org/press-releases/the-menopause-society-comments-on-the-fda-announcement-on-hormone-therapy
- Scarabin PY. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric. 2018;21(4):341-345. pubmed.ncbi.nlm.nih.gov/29570359/
- U.S. Food and Drug Administration. Menopause. Women's Health Topics. www.fda.gov/consumers/womens-health-topics/menopause
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.







